In his first interview since revealing both his Guillain-Barré syndrome diagnosis and the death of his partner Evans ...

To tell it to a 20-year-old Ryan Warsofky, a defenseman from Sacred Heart University relegated to exactly zero games as a ...

The Court noted that the petitioner’s husband had been in the ICU for almost nine months and had lost all ability to write or sign any bank document ...

BENGALURU: The Karnataka High Court appointed the wife of a retired man as his guardian to operate his three savings bank ...

In a new interview with Vulture, Sufjan Stevens opened up about his health following his 2023 diagnosis with Guillain-Barré ...

The self-declared “poster child of death in the music world” lost his partner and then got sick. But he’s trying to stay ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in ...

The GBS | CIDP Foundation International is making strides to increase awareness of Guillain-Barré Syndrome (GBS), Chronic ...

To further our strategic development plan, preparing to initiate the open-label tanruprubart FORWARD study, measuring pharmacokinetics, pharmacodynamics, early efficacy in week 1, and safety in up to ...

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compar ...